Dammarane-type saponins from the flower buds of Panax ginseng and their effects on human leukemia cells

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 1, 2010, Pages 309-314

  Tung, Nguyen Huu ^a   Song, Gyu Yong ^a   Kim, Jeong Ah ^a   Hyun, Jae Hee ^b   Kang, Hee Kyoung ^b   Kim, Young Ho ^a  

^a Chungnam National University   (South Korea)

^b Jeju National University School of Medicine   (South Korea)

Author keywords

Apoptosis; Araliaceae; Cytotoxic activity; Dammarane type saponin; Floralginsenoside; Ginsenoside; Panax ginseng

Indexed keywords

DAMMARANE DERIVATIVE; FLORALGINSENOSIDE TA; FLORALGINSENOSIDE TB; FLORALGINSENOSIDE TC; FLORALGINSENOSIDE TD; GINSENG EXTRACT; GINSENG SAPONIN; GINSENOSIDE; GINSENOSIDE F1; GINSENOSIDE F5; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BUD; CANCER INHIBITION; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYTOTOXICITY; DIPLOIDY; DRUG ISOLATION; DRUG STRUCTURE; FLOWER; GINSENG; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL; SPECTROSCOPY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; FLOWERS; HL-60 CELLS; HUMANS; LEUKEMIA; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR CONFORMATION; PANAX; SAPONINS; TRITERPENES;

ARALIACEAE; PANAX GINSENG;

EID: 72049084474     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.10.110     Document Type: Article

References (26)

1. Park J.D., Rhee D.K., and Lee Y.H. Phytochem. Rev. 4 (2005) 159
2. Shibata S. J. Korean Med. Sci. 16 (2001) 28
3. Dou D.Q., Chen Y.J., Liang L.H., Pang F.G., Shimizu N., and Takeda T. Chem. Pharm. Bull. 49 (2001) 442
4. Yoshikawa M., Sugimoto S., Nakamura S., Sakumae H., and Matsuda H. Chem. Pharm. Bull. 55 (2007) 1034
5. Wu L., Wang L., Gao H., Wu B., Song X., and Tang Z. Fitoterapia 78 (2007) 556
6. Ko S.R., Choi K.J., Suzuki K., and Suzuki Y. Chem. Pharm. Bull. 51 (2003) 404
7. Dou D., Chen Y., Ma Z., Wen Y., Weng M., Pei Y., Wang Z., Kawai H., Fukushima H., and Murakami Y. J. Chin. Pharm. Sci. 5 (1996) 48
8. 5N, 100 MHz): see Tables 1-3.
9. Yoshikawa M., Murakami T., Ueno T., Yashiro K., Hirokawa N., Murakami N., Yamahara J., Matsuda H., Saijoh R., and Tanaka O. Chem. Pharm. Bull. 45 (1997) 1039
10. Morikawa T., Xu F., Kashima Y., Matsuda H., Ninomiya K., and Yoshikawa M. Org. Lett. 6 (2004) 869
11. Qiu F., Ma Z.Z., Xu S.X., Yao X.S., Che C.T., and Chen Y.J. J. Asian Nat. Prod. Res. 3 (2001) 235
12. Karikura M., Miyase T., Tanizawa H., Taniyama T., and Takino Y. Chem. Pharm. Bull. 39 (1991) 400
13. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., and Mitchell J.B. Cancer Res. 47 (1987) 943
14. Shi Y., and Gaestel M. Biol. Chem. 383 (2002) 1519
15. Pearson G., Robinson F., Beers Gibson T., Xu B., Karandikar M., Berman K., and Cobb M.H. Endocr. Rev. 22 (2001) 153
16. Scheid M.P., and Woodgctt J.R. FEBS Lett. 546 (2003) 108
17. Nicholson K.M., and Anderson N.G. Cell Signalling 14 (2002) 381
18. 50 of compounds for 24 h. Cells were washed twice with PBS before being stained with 1 mg/mL Hoechst 33342 for 30 min at 37 °C. Apoptotic bodies, with condensed and fragmented nuclei, were observed with a fluorescence microscope (400×, BX-50, Olympus, Japan).
19. Hibasami H., Achiwa Y., Fujikawa T., and Komiya T. Anticancer Res. 16 (1996) 1943
20. Iwasaki R., Ito K., Ishida T., Hamanoue M., Adachi S., Watanabe T., and Sato Y. Cancer Sci. 100 (2009) 349
21. Milner J.A. J. Nutr. 136 (2006) 827S
22. Tan H., Ling H., He J., Yi L., Zhou J., Lin M., and Su Q. Arch. Pharm. Res. 31 (2008) 786
23. Lee E.H., Cho S.Y., Kim S.J., Shin E.S., Chang H.K., Kim D.H., Yeom M.H., Woe K.S., Lee J., Sim Y.C., and Lee T.R. J. Invest. Dermatol. 121 (2003) 607
24. Cai B.X., Jin S.L., Luo D., Lin X.F., and Gao J. Biol. Pharm. Bull. 32 (2009) 837
25. Wei C., Jia J., Liang P., and Guan Y. Neurosci. Lett. 443 (2008) 145
26. Keum Y.S., Han S.S., Chun K.S., Park J.H., Lee S.K., and Surh Y.J. Mutat. Res. 523 (2003) 75